Q1 2025 Holdings
Filed 2025-05-15 | 286 holdings | $16.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Booking Holdings Inc(BKNG) | COM | 09857L108 | $23.9M | 5,178 | 0.1% |
| Elevance Health Inc(ELV) | COM | 036752103 | $24.4M | 56,012 | 0.1% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $25.2M | 2,500,000 | 0.2% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $25.4M | 184,621 | 0.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $25.5M | 1,403,435 | 0.2% |
| CG Oncology Inc(CGON) | COM | 156944100 | $25.5M | 1,042,860 | 0.2% |
| Roblox Corp(RBLX) | CL A | 771049103 | $26.3M | 451,392 | 0.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $26.5M | 500,000 | 0.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $26.5M | 750,665 | 0.2% |
| Vtex(VTEX) | SHS CL A | G9470A102 | $27.6M | 5,443,476 | 0.2% |
| BBB Foods Inc(TBBB) | CL A COM | G0896C103 | $28.8M | 1,081,091 | 0.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $29.4M | 1,002,036 | 0.2% |
| Abbott Labs(ABT) | COM | 002824100 | $31.2M | 235,004 | 0.2% |
| Vertiv Holdings Co(VRT) | COM CL A | 92537N108 | $31.3M | 433,376 | 0.2% |
| Bank America Corp(BAC) | COM | 060505104 | $31.7M | 759,124 | 0.2% |
| Integer Hldgs Corp(ITGR) | COM | 45826H109 | $32.2M | 272,436 | 0.2% |
| Toast Inc(TOST) | CL A | 888787108 | $32.3M | 974,098 | 0.2% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $33.6M | 49,886 | 0.2% |
| Fidelity Natl Information SV(FIS) | COM | 31620M106 | $34.0M | 455,582 | 0.2% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $34.1M | 4,355,964 | 0.2% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $34.5M | 1,577,175 | 0.2% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $34.9M | 55,000 | 0.2% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $35.7M | 500,000 | 0.2% |
| Neuropace Inc(NPCE) | COM | 641288105 | $36.5M | 2,972,003 | 0.2% |
| Fabrinet(FN) | SHS | G3323L100 | $38.3M | 193,892 | 0.2% |
| Doximity Inc(DOCS) | CL A | 26622P107 | $38.9M | 670,636 | 0.2% |
| Merit MED SYS Inc(MMSI) | COM | 589889104 | $40.5M | 382,697 | 0.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $40.9M | 1,082,473 | 0.2% |
| Grab Holdings Limited(GRAB) | CLASS A ORD | G4124C109 | $41.7M | 9,196,353 | 0.3% |
| RLI Corp(RLI) | COM | 749607107 | $41.8M | 520,000 | 0.3% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $43.0M | 1,100,000 | 0.3% |
| First Amern Finl Corp(FAF) | COM | 31847R102 | $44.3M | 675,000 | 0.3% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $44.6M | 1,362,340 | 0.3% |
| Globant S A(GLOB) | COM | L44385109 | $44.7M | 379,738 | 0.3% |
| Hagerty Inc(HGTY) | CL A COM | 405166109 | $45.2M | 5,000,000 | 0.3% |
| Intercontinental Exchange in(ICE) | COM | 45866F104 | $45.6M | 264,295 | 0.3% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $46.1M | 2,250,000 | 0.3% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $46.5M | 2,365,294 | 0.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $47.5M | 471,113 | 0.3% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $47.9M | 541,379 | 0.3% |
| Zillow Group Inc(Z) | CL C CAP STK | 98954M200 | $49.5M | 722,617 | 0.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $49.8M | 150,220 | 0.3% |
| Trupanion Inc(TRUP) | COM | 898202106 | $50.3M | 1,350,000 | 0.3% |
| International Business Machs(IBM) | COM | 459200101 | $50.9M | 204,741 | 0.3% |
| Aflac Inc(AFL) | COM | 001055102 | $51.1M | 460,000 | 0.3% |
| Samsara Inc(IOT) | COM CL A | 79589L106 | $52.3M | 1,365,601 | 0.3% |
| First Solar Inc(FSLR) | COM | 336433107 | $52.7M | 417,069 | 0.3% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $52.8M | 1,788,868 | 0.3% |
| Brown & Brown Inc(BRO) | COM | 115236101 | $52.9M | 425,000 | 0.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $52.9M | 1,175,000 | 0.3% |